First Cancer Center in Thailand to Treat Patients Using Innovative Image-Guided Radiotherapy
By MedImaging International staff writers Posted on 09 Apr 2012 |

Image: The TrueBeam radiotherapy system (Photo courtesy of Varian Medical Systems).
Early in 2012, clinicians in Thailand treated a 63-year-old liver cancer patient with stereotactic ablative radiotherapy (SABR)—an effective technique of using high-energy radiation beams to destroy a tumor from outside the body, without performing surgery.
The Chulabhorn Hospital (Bangkok, Thailand) has become the first clinic in Thailand to begin treating cancer using the TrueBeam system developed by Varian Medical Systems (Palo Alto, CA, USA). “We determined that the lesion could not be excised surgically or treated with radiofrequency ablation because it was too close to the heart,” said Kanyanee Laebua, MD, head of radiation oncology at the hospital. “The TrueBeam system was ideal for this treatment. We were able to use RapidArc to approach the tumor from many different angles very quickly--an approach that maximizes dose to the tumor and minimizes exposure of surrounding healthy tissues. We did this using the TrueBeam system’s high intensity mode for delivering high doses very quickly. Dose delivery took less than two minutes once the patient was positioned for the treatment.”
The treatment was delivered in six sessions over a two-week period and each session was completed in considerably less time than is required with older technologies. “With TrueBeam, the fast dose delivery can enhance precision by helping us minimize the extent of tumor motion during treatment,” said Dr. Laebua. “Shorter treatment times may help patients find treatments less stressful, since they must be immobilized for each procedure.”
Clinicians at the Chulabhorn Hospital anticipate using their TrueBeam system chiefly for radiosurgical procedures to handle lung and liver cancer patients who are considered inoperable. “The image-guidance tools on the TrueBeam system are easier and faster for our clinicians to operate, compared with earlier generations of technology, and they enable us confirm the accuracy of our targeting during treatments,” said Dr. Laebua. “We look forward to offering more patients access to advanced types of radiotherapy that have the potential to increase tumor control rates.”
TrueBeam was designed to treat tumors with increased speed and accuracy, including tumors that move during treatment. It features several technical advnaces that dynamically synchronize and incorporate imaging, patient positioning, motion management, and treatment delivery during sophisticated treatments for cancer. With its high intensity mode, TrueBeam can accurately deliver high doses, more than twice as fast as earlier generations of technology.
“The TrueBeam system is Varian’s most advanced offering for radiosurgical procedures in the body, making it especially well-suited for treating cancer of the lung and liver, two types that occur commonly in Asia,” said Tom Duffy, head of Varian’s oncology systems business in Asia. “We are honored to work with the clinicians at the Chulabhorn Hospital, as they expand their capabilities on behalf of cancer patients in Thailand.”
Chulabhorn Hospital is one of the leading treatment centers in Thailand. The radiation oncology unit pioneered image-guided radiotherapy (IGRT) in Thailand and is the first TrueBeam system installation in Southeast Asia.
Related Links:
Varian Medical Systems
Chulabhorn Hospital
The Chulabhorn Hospital (Bangkok, Thailand) has become the first clinic in Thailand to begin treating cancer using the TrueBeam system developed by Varian Medical Systems (Palo Alto, CA, USA). “We determined that the lesion could not be excised surgically or treated with radiofrequency ablation because it was too close to the heart,” said Kanyanee Laebua, MD, head of radiation oncology at the hospital. “The TrueBeam system was ideal for this treatment. We were able to use RapidArc to approach the tumor from many different angles very quickly--an approach that maximizes dose to the tumor and minimizes exposure of surrounding healthy tissues. We did this using the TrueBeam system’s high intensity mode for delivering high doses very quickly. Dose delivery took less than two minutes once the patient was positioned for the treatment.”
The treatment was delivered in six sessions over a two-week period and each session was completed in considerably less time than is required with older technologies. “With TrueBeam, the fast dose delivery can enhance precision by helping us minimize the extent of tumor motion during treatment,” said Dr. Laebua. “Shorter treatment times may help patients find treatments less stressful, since they must be immobilized for each procedure.”
Clinicians at the Chulabhorn Hospital anticipate using their TrueBeam system chiefly for radiosurgical procedures to handle lung and liver cancer patients who are considered inoperable. “The image-guidance tools on the TrueBeam system are easier and faster for our clinicians to operate, compared with earlier generations of technology, and they enable us confirm the accuracy of our targeting during treatments,” said Dr. Laebua. “We look forward to offering more patients access to advanced types of radiotherapy that have the potential to increase tumor control rates.”
TrueBeam was designed to treat tumors with increased speed and accuracy, including tumors that move during treatment. It features several technical advnaces that dynamically synchronize and incorporate imaging, patient positioning, motion management, and treatment delivery during sophisticated treatments for cancer. With its high intensity mode, TrueBeam can accurately deliver high doses, more than twice as fast as earlier generations of technology.
“The TrueBeam system is Varian’s most advanced offering for radiosurgical procedures in the body, making it especially well-suited for treating cancer of the lung and liver, two types that occur commonly in Asia,” said Tom Duffy, head of Varian’s oncology systems business in Asia. “We are honored to work with the clinicians at the Chulabhorn Hospital, as they expand their capabilities on behalf of cancer patients in Thailand.”
Chulabhorn Hospital is one of the leading treatment centers in Thailand. The radiation oncology unit pioneered image-guided radiotherapy (IGRT) in Thailand and is the first TrueBeam system installation in Southeast Asia.
Related Links:
Varian Medical Systems
Chulabhorn Hospital
Latest Radiography News
- World's Largest Class Single Crystal Diamond Radiation Detector Opens New Possibilities for Diagnostic Imaging
- AI-Powered Imaging Technique Shows Promise in Evaluating Patients for PCI
- Higher Chest X-Ray Usage Catches Lung Cancer Earlier and Improves Survival
- AI-Powered Mammograms Predict Cardiovascular Risk
- Generative AI Model Significantly Reduces Chest X-Ray Reading Time
- AI-Powered Mammography Screening Boosts Cancer Detection in Single-Reader Settings
- Photon Counting Detectors Promise Fast Color X-Ray Images
- AI Can Flag Mammograms for Supplemental MRI
- 3D CT Imaging from Single X-Ray Projection Reduces Radiation Exposure
- AI Method Accurately Predicts Breast Cancer Risk by Analyzing Multiple Mammograms
- Printable Organic X-Ray Sensors Could Transform Treatment for Cancer Patients
- Highly Sensitive, Foldable Detector to Make X-Rays Safer
- Novel Breast Cancer Screening Technology Could Offer Superior Alternative to Mammogram
- Artificial Intelligence Accurately Predicts Breast Cancer Years Before Diagnosis
- AI-Powered Chest X-Ray Detects Pulmonary Nodules Three Years Before Lung Cancer Symptoms
- AI Model Identifies Vertebral Compression Fractures in Chest Radiographs
Channels
MRI
view channel
AI Tool Tracks Effectiveness of Multiple Sclerosis Treatments Using Brain MRI Scans
Multiple sclerosis (MS) is a condition in which the immune system attacks the brain and spinal cord, leading to impairments in movement, sensation, and cognition. Magnetic Resonance Imaging (MRI) markers... Read more
Ultra-Powerful MRI Scans Enable Life-Changing Surgery in Treatment-Resistant Epileptic Patients
Approximately 360,000 individuals in the UK suffer from focal epilepsy, a condition in which seizures spread from one part of the brain. Around a third of these patients experience persistent seizures... Read more
AI-Powered MRI Technology Improves Parkinson’s Diagnoses
Current research shows that the accuracy of diagnosing Parkinson’s disease typically ranges from 55% to 78% within the first five years of assessment. This is partly due to the similarities shared by Parkinson’s... Read more
Biparametric MRI Combined with AI Enhances Detection of Clinically Significant Prostate Cancer
Artificial intelligence (AI) technologies are transforming the way medical images are analyzed, offering unprecedented capabilities in quantitatively extracting features that go beyond traditional visual... Read moreUltrasound
view channel.jpeg)
AI-Powered Lung Ultrasound Outperforms Human Experts in Tuberculosis Diagnosis
Despite global declines in tuberculosis (TB) rates in previous years, the incidence of TB rose by 4.6% from 2020 to 2023. Early screening and rapid diagnosis are essential elements of the World Health... Read more
AI Identifies Heart Valve Disease from Common Imaging Test
Tricuspid regurgitation is a condition where the heart's tricuspid valve does not close completely during contraction, leading to backward blood flow, which can result in heart failure. A new artificial... Read moreNuclear Medicine
view channel
Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors
Interleukin-13 receptor α-2 (IL13Rα2) is a cell surface receptor commonly found in solid tumors such as glioblastoma, melanoma, and breast cancer. It is minimally expressed in normal tissues, making it... Read more
Novel PET Imaging Approach Offers Never-Before-Seen View of Neuroinflammation
COX-2, an enzyme that plays a key role in brain inflammation, can be significantly upregulated by inflammatory stimuli and neuroexcitation. Researchers suggest that COX-2 density in the brain could serve... Read moreGeneral/Advanced Imaging
view channel
AI-Powered Imaging System Improves Lung Cancer Diagnosis
Given the need to detect lung cancer at earlier stages, there is an increasing need for a definitive diagnostic pathway for patients with suspicious pulmonary nodules. However, obtaining tissue samples... Read more
AI Model Significantly Enhances Low-Dose CT Capabilities
Lung cancer remains one of the most challenging diseases, making early diagnosis vital for effective treatment. Fortunately, advancements in artificial intelligence (AI) are revolutionizing lung cancer... Read moreImaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
GE HealthCare (Chicago, IL, USA) has entered into a collaboration with NVIDIA (Santa Clara, CA, USA), expanding the existing relationship between the two companies to focus on pioneering innovation in... Read more
Patient-Specific 3D-Printed Phantoms Transform CT Imaging
New research has highlighted how anatomically precise, patient-specific 3D-printed phantoms are proving to be scalable, cost-effective, and efficient tools in the development of new CT scan algorithms... Read more
Siemens and Sectra Collaborate on Enhancing Radiology Workflows
Siemens Healthineers (Forchheim, Germany) and Sectra (Linköping, Sweden) have entered into a collaboration aimed at enhancing radiologists' diagnostic capabilities and, in turn, improving patient care... Read more